Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

John Mascarenhas, Maria R. Baer, Craig Kessler, Elizabeth Hexner, Douglas Tremblay, Leah Price, Lonette Sandy, Rona Weinberg, Heike Pahl, Lewis R. Silverman, Judith D. Goldberg, Heidi Kosiorek, Amylou C. Dueck, Ronald Hoffman

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1343-1345
Number of pages3
JournalLeukemia and Lymphoma
Issue number5
StatePublished - Apr 16 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this